Interstitial lung diseases comprise a diverse group of disorders characterized by progressive lung damage and fibrosis. This session will focus on the diagnosis, pathogenesis, and management of interstitial lung diseases. Researchers will discuss advances in imaging, biomarkers, and therapeutic interventions. Emerging approaches in pulmonary fibrosis research will be highlighted.
Presentations will explore idiopathic pulmonary fibrosis, connective tissue disease-associated ILD, and rare interstitial lung disorders. Participants will gain insights into multidisciplinary care models and personalized treatment strategies. Recent clinical trials and translational studies will also be discussed. Novel therapeutic targets will be presented.
The session will address challenges associated with early diagnosis and disease progression. Experts will discuss future perspectives in ILD research and patient care. Collaborative initiatives aimed at improving clinical outcomes will be emphasized. This session aims to promote advancements in interstitial lung disease management.